June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Genistein ameliorates diabetic retinopathy by suppression of oxidative stress, inflammation and angiogenic markers in streptozotocin induced retinal neovascularization in neonatal rats (nSTZ).
Author Affiliations & Notes
  • SHIRISH Satish DONGARE
    Ocular Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India
  • Suresh Kumar Gupta
    Ocular Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India
  • Rajani Mathur
    Ocular Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India
  • Rohit Saxena
    Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  • Sushma Srivastava
    Ocular Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India
  • Tapas C Nag
    Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India
  • Footnotes
    Commercial Relationships SHIRISH DONGARE, None; Suresh Gupta, None; Rajani Mathur, None; Rohit Saxena, None; Sushma Srivastava, None; Tapas Nag, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 175. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      SHIRISH Satish DONGARE, Suresh Kumar Gupta, Rajani Mathur, Rohit Saxena, Sushma Srivastava, Tapas C Nag; Genistein ameliorates diabetic retinopathy by suppression of oxidative stress, inflammation and angiogenic markers in streptozotocin induced retinal neovascularization in neonatal rats (nSTZ).. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):175.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: This study evaluates effect of isoflavone Genistein (300 mg/kg/day, po) on retinal oxidative stress, inflammation and neovascularization in nSTZ.

Methods: Streptozotocin (STZ 90mg/kg; i.p.) was administrated to two days old rat pups and six weeks later fasting glucose level (FGL) was checked. Animals with FGL ≥ 160 mg/dl were identified as diabetic and included in study that was carried out for 24 weeks. The diabetic animals were randomly divided into two groups (n=16) diabetic control (DC) and genistein treated (Gnst) and data was compared against age matched normal animals (NC). The animals were evaluated for retinal total antioxidant capacity (TAC), Tumor Necrosis Factor-α (TNF-α), vascular endothelial growth factor (VEGF), vessel abnormalities, vascular leakage, Immunohistochemistry also performed for nuclear factor kappa B (NF-kB) and caspase-3. Ultra-structural changes were evaluated by transmission electron microscopic (TEM) studies.

Results: TAC level of retinas were significantly decreased in DC as compared to NC whereas, Gnst protected against depletion of TAC level. A significant rise in the levels of VEGF and TNF-α in DC (16.20±3.28 & 71.90±10.24 pg/ml, respectively) was observed as compared to NC (6.45±2.18 & 29.82±3.38 pg/ml, respectively) however, it was significantly reduced in Gnst (9.32±2.10 & 38.70±9.83 pg/ml, respectively). Diameters of retinal arterioles and venules were significantly increased in DC retinas as compared to NC but, restored in Gnst retinal vessels. Fundus fluorescein angiograms from DC showed increased retinal vascular permeability and leakage, that was absent in Gnst. Retinal immunoreactivity (NF-kB and caspase-3) was raised in DC compared to the other groups. TEM observation revealed thickened BM (0.23±0.04 µm) in DC as compared to NC (0.07±0.01 µm) but, comparatively thin in Gnst (0.16±0.02 µm).

Conclusions: The results of the present study demonstrate that Genistein protects against retinal oxidative stress, inflammation and angiogenesis in streptozotocin induced retinal neovascularization in neonatal rats.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×